FdaApplication
NDA 020173
Identifiers
- fda_app_no: NDA020173
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | NDA |
| approval_date | 1995-10-27 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER | AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE | 5.5%;102MG/100ML;522MG/100ML;431MG/100ML;224MG/100ML | INJECTABLE;INJECTION |
| TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER | AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE | 8.5%;102MG/100ML;522MG/100ML;594MG/100ML;154MG/100ML | INJECTABLE;INJECTION |
2 products